Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
92 studies found for:    formaldehyde
Show Display Options
Rank Status Study
1 Completed Carnoy`s Solution Versus Formalin in Rectal Cancer Specimens Following Neoadjuvant Chemoradiation: a Randomized Trial
Condition: Rectal Cancer
Interventions: Other: Carnoy's solution;   Other: 10% neutral buffered formaldehyde
2 Withdrawn Role of Indoor Pollutants on House Dust Mite Allergic Asthma
Conditions: Allergic Asthma;   Allergy to House Dust Mite
Interventions: Other: Formaldehyde and NO2 (Exposure to indoor pollutants);   Other: Placebo (Exposure to indoor pollutants)
3 Completed Studying Blood Toxicity in Workers Exposed to Formaldehyde
Conditions: Blood;   Chemical Industry
4 Completed Association of Formaldehyde Exposure to Myeloid Leukemia in Workers in Guangdong, China
Conditions: Epidemiology;   Industrial Hygiene;   Neoplasms
5 Completed Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule
Condition: Encephalitis, Tick-Borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
6 Completed Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)
Condition: Encephalitis, Tick-borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
7 Completed Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine
Condition: Ross River Virus Disease (RRVD)
Intervention: Biological: Formalin-treated, UV-inactivated, whole-virion, Vero cell-derived, preservative free Ross River Virus (RRV) vaccine with or without an Al(OH)3 adjuvant
8 Completed Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children
Condition: Encephalitis, Tick-borne
Intervention: Biological: Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl
9 Unknown  Safety of Formalin-free Fixatives for In-Vivo Fixation of Skin Lesions.
Condition: Skin Abnormality
Intervention: Device: Formulations for in-vivo fixation
10 Recruiting Diagnostic Accuracy of Polymerase Chain Reaction for Mycobacterium Tuberculosis Using EBUS-TBNA Samples
Conditions: Lymphadenopathy;   Tuberculosis;   Sarcoidosis
Interventions: Device: Nested PCR for formalin-fixed tissues;   Device: Nested PCR for fresh tissues;   Device: Real-time PCR for fresh tissues
11 Completed Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E Histology
Conditions: Basal Cell Carcinoma;   Squamous Cell Carcinoma
12 Completed Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders
Conditions: Soil-transmitted Helminthiasis;   Schistosomiasis;   Strongyloidiasis;   Shigellosis;   Intestinal Salmonellosis;   Campylobacteriosis;   Aeromonas Spp. Infections;   Giardiasis;   Amoebiasis;   Dientamoebiasis;   Cryptosporidium Spp. Infections
Interventions: Procedure: Stool culturing for pathogenic bacteria;   Procedure: Kato-Katz technique;   Procedure: Baermann technique;   Device: Mini-FLOTAC;   Device: Crypto/Giardia Duo Strip;   Procedure: Formalin-ether concentration technique;   Device: CCA RDT;   Procedure: Koga agar plate culture;   Procedure: Kinyoun staining;   Device: Multiplex PCR;   Procedure: Metagenomics analysis
13 Completed Chlorhexidine Mouthrinses and Plaque Control
Condition: Dental Plaque
Interventions: Drug: Synthodont;   Drug: Soludent
14 Withdrawn Microporous Polysaccharide Hemospheres Epistaxis
Condition: Epistaxis
Interventions: Device: Microporous Polysaccharide Hemospheres;   Device: Nasal Tampon
15 Completed Influence of Persistent CMV-infection on Immune Senescence
Condition: Immune Senescence
Intervention: Biological: Vaccination against TBEV (FSME Immun CC)
16 Completed Clinical Verification of Peptide Biomarkers for Human Aging
Condition: Aging
17 Terminated Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Tumor Sample;   Procedure: Serum Sample
18 Completed Semi-Quantification of Her2/Neu Protein Expression in Formalin Fixed, Paraffin-Embedded Normal and Neoplastic Tissue
Condition: Breast Cancer
19 Completed Identification and Semi -Quantification of ER/PR Proteins Expression
Condition: Breast Cancer
Interventions: Procedure: Breast Cancer patient;   Procedure: Cancer patients
20 Completed Identification and Semi-Quantification of Ki-67 Protein Expression Status
Condition: Breast Cancer
Intervention: Procedure: Women with Breast Cancer

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.